1. Home
  2. EVO
  3. EVO News

Latest Evotec SE (EVO) News on March 31, 2025

EVO

Morningstar Research

24 days ago

Analyst Report: Evotec SE

EVO

MT Newswires

a month ago

Evotec Receives $20 Million Research Payment From Bristol Myers Squibb

Evotec Announces Key Progress in Neuroscience Collaboration with Bristol Myers Squibb
EVO

ACCESS Newswire

a month ago

Evotec Announces Key Progress in Neuroscience Collaboration with Bristol Myers Squibb

EVO

MT Newswires

a month ago

Evotec Names Paul Hitchin as Chief Financial Officer

Evotec Announces Change in Management Board
EVO

ACCESS Newswire

a month ago

Evotec Announces Change in Management Board

EVO

MT Newswires

2 months ago

Evotec to Receive Grant From Korea Institute of Advanced Technology to Fund Lung Disease Treatments

Evotec Receives Grant from Korean Government to Develop Novel Antibody-based Treatments for Lung Diseases
EVO

ACCESS Newswire

2 months ago

Evotec Receives Grant from Korean Government to Develop Novel Antibody-based Treatments for Lung Diseases

EVO

MT Newswires

4 months ago

Evotec, Novo Nordisk Drug Discovery Accelerator Selects First Three Projects for Cardiometabolic Conditions

Evotec SE announces first projects for LAB eN(2) drug discovery accelerator with Novo Nordisk
EVO

ACCESSWIRE

4 months ago

Evotec SE announces first projects for LAB eN(2) drug discovery accelerator with Novo Nordisk

EVO

MT Newswires

4 months ago

Sector Update: Health Care Stocks Rise in Afternoon Trading

EVO

MT Newswires

4 months ago

Evotec Chief Operating Officer to Step Down at End of December

Evotec Announces Change in Management Board
EVO

ACCESSWIRE

4 months ago

Evotec Announces Change in Management Board

HALO Withdraws Acquisition Bid for EVO, Reaffirms '24 View, Stock Up
EVO

Zacks

4 months ago

HALO Withdraws Acquisition Bid for EVO, Reaffirms '24 View, Stock Up

EVO

Morningstar Research

4 months ago

Analyst Report: Evotec SE

Halozyme Withdraws Evotec Bid After Rebuff, Reaffirms Strong Growth Outlook
EVO

Benzinga

4 months ago

Halozyme Withdraws Evotec Bid After Rebuff, Reaffirms Strong Growth Outlook

Comment on Withdrawn Non-Binding Offer
EVO

ACCESSWIRE

4 months ago

Comment on Withdrawn Non-Binding Offer

EVO

Investing.com

4 months ago

Halozyme shares jump 12% as it scraps $2.1 bln Evotec deal

EVO

MT Newswires

4 months ago

Update: Halozyme Therapeutics Withdraws Proposal to Acquire Evotec

EVO

MT Newswires

4 months ago

Sector Update: Health Care

EVO

MT Newswires

4 months ago

Halozyme Therapeutics Withdraws Proposal to Acquire Evotec

Halozyme Withdraws Proposal to Acquire Evotec Following Evotec's Unwillingness to Engage in Discussions
EVO

PR Newswire

4 months ago

Halozyme Withdraws Proposal to Acquire Evotec Following Evotec's Unwillingness to Engage in Discussions

Halozyme drops Evotec buyout bid; Patient dies in Neurogene trial
EVO

BioPharma Dive

4 months ago

Halozyme drops Evotec buyout bid; Patient dies in Neurogene trial

EVO

Morningstar Research

4 months ago

Analyst Report: Evotec SE

Is Evotec SE (EVO) the Best German Stock to Buy Now?
EVO

Insider Monkey

4 months ago

Is Evotec SE (EVO) the Best German Stock to Buy Now?

EVO

Morningstar Research

4 months ago

Analyst Report: Evotec SE

Halozyme Provides Update on Non-Binding Proposal to Combine with Evotec
EVO

PR Newswire

4 months ago

Halozyme Provides Update on Non-Binding Proposal to Combine with Evotec

Halozyme to Fund Proposed Evotec Takeover in Cash, CEO Says
EVO

Bloomberg

4 months ago

Halozyme to Fund Proposed Evotec Takeover in Cash, CEO Says

EVO

Morningstar Research

4 months ago

Morningstar | A Weekly Summary of Stock Ideas and Developments in the Companies We Cover

EVO

Morningstar Research

4 months ago

Analyst Report: Evotec SE

Large Pharma Partner Halozyme Therapeutics Offers To Acquire Germany-Based Evotec For ~$2 Billion
EVO

Benzinga

4 months ago

Large Pharma Partner Halozyme Therapeutics Offers To Acquire Germany-Based Evotec For ~$2 Billion

Halozyme Submits $2.11 Billion Acquisition Offer For Evotec
EVO

MT Newswires

4 months ago

Halozyme Submits $2.11 Billion Acquisition Offer For Evotec

EVO

Investing.com

5 months ago

Evotec shares surge 20% on Halozyme's 2 billion euro takeover bid

Halozyme bids for Evotec; BeiGene gets a new name
EVO

BioPharma Dive

5 months ago

Halozyme bids for Evotec; BeiGene gets a new name

Germany’s Evotec Gets Takeover Interest From Halozyme
EVO

Bloomberg

5 months ago

Germany’s Evotec Gets Takeover Interest From Halozyme

Comment on Media Report
EVO

ACCESSWIRE

5 months ago

Comment on Media Report

EVO

MT Newswires

5 months ago

Halozyme Proposes to Acquire Evotec for 11 Euros per Share

Halozyme Confirms Proposal to Combine with Evotec for €11.00 Per Share in an All-Cash Transaction
EVO

PR Newswire

5 months ago

Halozyme Confirms Proposal to Combine with Evotec for €11.00 Per Share in an All-Cash Transaction

Evotec Third Quarter 2024 Earnings: Misses Expectations
EVO

Simply Wall St.

5 months ago

Evotec Third Quarter 2024 Earnings: Misses Expectations

EVO

MT Newswires

5 months ago

Market Chatter: Evotec Attracts Potential Takeover Bid From Triton Partners; Shares Up

Triton Weighs Takeover Deal for Drug Developer Evotec
EVO

Bloomberg

5 months ago

Triton Weighs Takeover Deal for Drug Developer Evotec

Private Equity Triton Partners Takes Around 10% Stake In Evotec, Reportedly Mulls Potential Takeover Deal
EVO

Benzinga

5 months ago

Private Equity Triton Partners Takes Around 10% Stake In Evotec, Reportedly Mulls Potential Takeover Deal

EVO

MT Newswires

5 months ago

Top Premarket Gainers

Earnings Release: Here's Why Analysts Cut Their Evotec SE (ETR:EVT) Price Target To €10.65
EVO

Simply Wall St.

5 months ago

Earnings Release: Here's Why Analysts Cut Their Evotec SE (ETR:EVT) Price Target To €10.65

EVO

Morningstar Research

5 months ago

Analyst Report: Evotec SE

Evotec SE (EVOTF) Q3 2024 Earnings Call Highlights: Navigating Market Challenges with Strategic ...
EVO

GuruFocus.com

5 months ago

Evotec SE (EVOTF) Q3 2024 Earnings Call Highlights: Navigating Market Challenges with Strategic ...

EVO

MT Newswires

5 months ago

Sector Update: Health Care Stocks Advance Pre-Bell Wednesday

EVO

MT Newswires

5 months ago

Evotec's Q3 Net Loss Flat, Revenue Falls

Evotec SE Reports 9M 2024 Results: Strategic Progress and Successful Expansion Amid Challenging Market Conditions
EVO

ACCESSWIRE

5 months ago

Evotec SE Reports 9M 2024 Results: Strategic Progress and Successful Expansion Amid Challenging Market Conditions

Evotec SE (EVO) Q3 2024 Earnings Report Preview: What To Expect
EVO

GuruFocus.com

5 months ago

Evotec SE (EVO) Q3 2024 Earnings Report Preview: What To Expect

Evotec Announces Sale of API Manufacturing Facility to Monacum Partners
EVO

ACCESSWIRE

5 months ago

Evotec Announces Sale of API Manufacturing Facility to Monacum Partners

EVO

Morningstar Research

5 months ago

Analyst Report: Evotec SE

Evotec SE to Announce Results for the First Nine Months 2024 on 06 November 2024
EVO

ACCESSWIRE

5 months ago

Evotec SE to Announce Results for the First Nine Months 2024 on 06 November 2024

EVO

MT Newswires

5 months ago

Evotec to Receive $50 Million Payment Under Bristol Myers Squibb Partnership

Evotec and Bristol Myers Squibb Expand Proteomics Partnership
EVO

ACCESSWIRE

5 months ago

Evotec and Bristol Myers Squibb Expand Proteomics Partnership

Even after rising 11% this past week, Evotec (ETR:EVT) shareholders are still down 84% over the past three years
EVO

Simply Wall St.

6 months ago

Even after rising 11% this past week, Evotec (ETR:EVT) shareholders are still down 84% over the past three years

EVO

MT Newswires

6 months ago

Evotec, Novo Nordisk Partner on Cell Therapies

Evotec and Novo Nordisk Enter into Technology Development Partnership to Support Next-Generation Cell Therapies
EVO

ACCESSWIRE

6 months ago

Evotec and Novo Nordisk Enter into Technology Development Partnership to Support Next-Generation Cell Therapies

Evotec opens first European biologics facility in France
EVO

Investment Monitor

6 months ago

Evotec opens first European biologics facility in France

EVO

MT Newswires

6 months ago

Evotec Opens J.POD Biologics Facility in France

Just - Evotec Biologics Opens Cutting-Edge Biologics Facility - J.POD(R) Toulouse, France (EU)
EVO

ACCESSWIRE

6 months ago

Just - Evotec Biologics Opens Cutting-Edge Biologics Facility - J.POD(R) Toulouse, France (EU)

Evotec partners X-Chem for tech-enabled drug discovery
EVO

Pharmaceutical Technology

7 months ago

Evotec partners X-Chem for tech-enabled drug discovery

EVO

MT Newswires

7 months ago

Evotec, X-Chem to Collaborate on Early-Stage Drug Discovery

Evotec and X-Chem Collaborate to Accelerate Early-Stage Drug Discovery
EVO

Business Wire

7 months ago

Evotec and X-Chem Collaborate to Accelerate Early-Stage Drug Discovery

EVO

MT Newswires

7 months ago

Sector Update: Health Care Stocks Lean Lower Pre-Bell Tuesday

EVO

MT Newswires

7 months ago

Evotec Chief Business Officer Matthias Evers Steps Down

Evotec Announces Change in Management Board
EVO

ACCESSWIRE

7 months ago

Evotec Announces Change in Management Board

Evotec Second Quarter 2024 Earnings: EPS Misses Expectations
EVO

Simply Wall St.

7 months ago

Evotec Second Quarter 2024 Earnings: EPS Misses Expectations

Analysts Have Been Trimming Their Evotec SE (ETR:EVT) Price Target After Its Latest Report
EVO

Simply Wall St.

7 months ago

Analysts Have Been Trimming Their Evotec SE (ETR:EVT) Price Target After Its Latest Report

Evotec slashes workforce by 400 people in “difficult market”
EVO

Pharmaceutical Technology

8 months ago

Evotec slashes workforce by 400 people in “difficult market”

EVO

Morningstar Research

8 months ago

Analyst Report: Evotec SE

Bristol Myers' German Partner Evotec Plans Layoffs, Cites 'Challenging Revenues, Profitability'
EVO

Benzinga

8 months ago

Bristol Myers' German Partner Evotec Plans Layoffs, Cites 'Challenging Revenues, Profitability'

Evotec (EVO) Rises 12% on $75M Milestone Payment From BMY
EVO

Zacks

8 months ago

Evotec (EVO) Rises 12% on $75M Milestone Payment From BMY

Evotec, citing research spending slowdown, cuts jobs and exits gene therapy
EVO

BioPharma Dive

8 months ago

Evotec, citing research spending slowdown, cuts jobs and exits gene therapy

EVO

MT Newswires

8 months ago

Evotec Q2 Loss Widens, Revenue Rises

Evotec SE Reports H1 2024 Results: Challenging Year; Priority Reset for Sustainable Profitable Growth Gaining Momentum, Building on Core Strengths
EVO

ACCESSWIRE

8 months ago

Evotec SE Reports H1 2024 Results: Challenging Year; Priority Reset for Sustainable Profitable Growth Gaining Momentum, Building on Core Strengths

EVO

MT Newswires

8 months ago

Evotec Reports Progress in Partnership With Bristol-Myers Squibb

Evotec Announces Strong Progress in Strategic Protein Degradation Partnership with Bristol Myers Squibb
EVO

ACCESSWIRE

8 months ago

Evotec Announces Strong Progress in Strategic Protein Degradation Partnership with Bristol Myers Squibb

EVO

Morningstar Research

8 months ago

Analyst Report: Evotec SE

EVO

MT Newswires

8 months ago

Evotec Receives $25 Million Under Neuroscience Partnership With Bristol-Myers Squibb

Evotec Announces Progress in Strategic Neuroscience Partnership with Bristol Myers Squibb
EVO

ACCESSWIRE

8 months ago

Evotec Announces Progress in Strategic Neuroscience Partnership with Bristol Myers Squibb

EVO

Investing.com

8 months ago

Midday movers: Super Micro Computer, Airbnb and Lyft fall; Shopify rises

Evotec SE Reports First Half-year 2024 Results on 14 August 2024
EVO

ACCESSWIRE

8 months ago

Evotec SE Reports First Half-year 2024 Results on 14 August 2024

EVO

Investing.com

8 months ago

Evotec shares crash 36% on profit warning

EVO

Morningstar Research

8 months ago

Analyst Report: Evotec SE

Evotec Provides Guidance Update
EVO

ACCESSWIRE

8 months ago

Evotec Provides Guidance Update

Evotec SE Provides Guidance Update
EVO

ACCESSWIRE

8 months ago

Evotec SE Provides Guidance Update

Evotec SE's (ETR:EVT) largest shareholders are retail investors with 48% ownership, institutions own 36%
EVO

Simply Wall St.

8 months ago

Evotec SE's (ETR:EVT) largest shareholders are retail investors with 48% ownership, institutions own 36%

Evotec and Pfizer announce drug discovery collaboration
EVO

Pharmaceutical Technology

9 months ago

Evotec and Pfizer announce drug discovery collaboration

EVO

MT Newswires

9 months ago

Evotec, Pfizer Enter Research Collaboration on Metabolic, Infectious Diseases

Evotec and Pfizer Collaborate to Advance Drug Discovery in France
EVO

ACCESSWIRE

9 months ago

Evotec and Pfizer Collaborate to Advance Drug Discovery in France

EVO

MT Newswires

9 months ago

Evotec's Biologics Segment Expands Sandoz Partnership

Just - Evotec Biologics Expands Tech Partnership for Biosimilars with Sandoz
EVO

ACCESSWIRE

9 months ago

Just - Evotec Biologics Expands Tech Partnership for Biosimilars with Sandoz

EVO

Morningstar Research

9 months ago

Analyst Report: Evotec SE

EVO

MT Newswires

9 months ago

Evotec Subsidiary Gets Multi-Year US Defense Department Contract for Up to $39 Million

Just - Evotec Biologics selected by U.S. Department of Defense for Manufacturing Optimization Program
EVO

ACCESSWIRE

9 months ago

Just - Evotec Biologics selected by U.S. Department of Defense for Manufacturing Optimization Program

EVO

Morningstar Research

9 months ago

Analyst Report: Evotec SE

EVO

MT Newswires

10 months ago

Evotec Gets $20 Million Milestone Payment in Neurodegenerative Disease Collaboration With Bristol Myers Squibb

Evotec Announces Progress in Neuroscience Collaboration with Bristol Myers Squibb
EVO

ACCESSWIRE

10 months ago

Evotec Announces Progress in Neuroscience Collaboration with Bristol Myers Squibb

Evotec SE: Results of the Annual General Meeting 2024
EVO

ACCESSWIRE

10 months ago

Evotec SE: Results of the Annual General Meeting 2024

EVO

MT Newswires

10 months ago

Evotec Partners With French Institutions, Company to Research Obesity

Share on Social Networks: